
    
      A prospective pilot single center study to investigate the potential of [TIMP-2].[IGFBP-7] to
      predict AKI (Acute Kidney Injury) in patients undergoing major abdominal surgery. The
      investigators will measure the biomarker once preoperatively and 4-times postoperatively
      starting at arrival on PACU (post anesthesia care unit).The primary endpoint of this study is
      the development of AKI stage 2 or 3 within the first 72 postoperative hours.
    
  